Statutory Rules of Northern Ireland
2015 No. 54
Dangerous Drugs
The Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2015
Made
12th February 2015
Coming into operation
5th March 2015
The Department of Health, Social Services and Public Safety makes the following Order in exercise of the powers conferred by section 7(4) of the Misuse of Drugs Act 1971(1) as adapted by section 7(9) of that Act and now vested in it(2) and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act.
Citation, commencement and interpretation
1.—(1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2015 and shall come into operation on 5th March 2015.
(2) The Interpretation Act (Northern Ireland) 1954(3) shall apply to this Order as it applies to an Act of the Northern Ireland Assembly.
Amendment to the Misuse of Drugs (Designation) Order (Northern Ireland) 2001
2.—(1) The Misuse of Drugs (Designation) Order (Northern Ireland) 2001(4) is amended as follows.
(2) In paragraph 1(a) of Part 1 of the Schedule,
(a)after “Tenocyclidine” insert—
“(6aR,9R)-4-acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ALD-52)”
(b)after “4-Bromo-2, 5-dimethoxy-a-methylphenethylamine” insert—
“3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)
(6aR,9R)-N,N-diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD)
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD)
(6aR,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD)”
(c)after “2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol” insert—
“2,4-dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg]quinolin-9-yl}methanone (LSZ)”
(3) For paragraph 1(b) of Part 1 of the Schedule, substitute—
“(b)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say—
(i)by substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;
(ii)by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;
(iii)by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;
(iv)by substitution at the 2-position of the tryptamine ring system with an alkyl substituent;”.
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 12th February 2015
Dr Paddy Woods
A senior officer of the
Department of Health, Social Services and Public Safety
EXPLANATORY NOTE
(This note is not part of the Order)
Section 7(3) of the Misuse of Drugs Act 1971 requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 by inserting the synthetic opiate (known as AH-7921) and LSD related compounds into Part 1 of the Schedule to that Order. This Order also replaces the definition of tryptamine compounds in Part 1 of the Schedule with a wider generic definition.
1971 c.38 as amended by s.151 of and Schedule 17 to the Police Reform and Social Responsibility Act 2011 c.13.
S.R.&O.(N.I.)1973 No.504, Article 5(a) and S.I.1999/283 (N.I.1), Article 3(6)
S.R. 2001 No. 431 relevant amending Orders are S.R. 2014 Nos. 262, 159 and 20, S.R. 2013 No.77, S.R. 2012 No.212, S.R. 2011 No. 154, S.R. 2010 Nos.246 and 149, S.R. 2009 No.389 and S.R. 2005 No.359